REG-Resolution Adopted at the Extraordinary General Meeting of Genmab A/S Including Grant of Restricted Stock Units to Board Members
Genmab A/S held its Extraordinary General Meeting, which approved the Board of Directors' 2026 remuneration proposal including share-based compensation. A total of 5,300 restricted stock units were granted to board members at a fair value of DKK 2,487.00 per unit, vesting after three years.
Key figures
- Rsus granted
- 5300
- Vesting period
- 3 years
- Rsu fair value dkk
- 2487
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.